Get the Stockscreener App
1.15
5.74%
-0.07
After Hours:
1.23
0.08
+6.96%
Enveric Biosciences Inc stock is traded at $1.15, with a volume of 162.84K.
It is down -5.74% in the last 24 hours and down -6.50% over the past month.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
See More
Previous Close:
$1.22
Open:
$1.23
24h Volume:
162.84K
Relative Volume:
0.73
Market Cap:
$2.84M
Revenue:
-
Net Income/Loss:
$-15.08M
P/E Ratio:
-0.1791
EPS:
-6.42
Net Cash Flow:
$-11.56M
1W Performance:
-12.21%
1M Performance:
-6.50%
6M Performance:
-44.98%
1Y Performance:
-85.48%
1-Day Range:
$1.14
$1.2342
1-Week Range:
$1.14
$1.33
52-Week Range:
$1.01
$8.949
Enveric Biosciences Inc Stock (ENVB) Company Profile
Name
Enveric Biosciences Inc
Sector
Industry
Phone
239-302-1707
Address
4851 TAMIAMI TRAIL N, SUITE 200, NAPLES
Compare ENVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENVB
Enveric Biosciences Inc
|
1.15 | 3.02M | 0 | -15.08M | -11.56M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Enveric Biosciences Inc Stock (ENVB) Latest News
What catalysts could drive Enveric Biosciences Inc. stock higher in 2025Maximize returns with strategic stock selection - jammulinksnews.com
What are the technical indicators suggesting about Enveric Biosciences Inc.Outstanding risk-reward balance - jammulinksnews.com
How does Enveric Biosciences Inc. compare to its industry peersBuild wealth steadily with proven stock picks - jammulinksnews.com
How does Enveric Biosciences Inc. generate profit in a changing economyFree Stock Market Mentorship - jammulinksnews.com
What institutional investors are buying Enveric Biosciences Inc. stockRetirement Planning Watchlist For Fast Growth - jammulinksnews.com
Is Enveric Biosciences Inc. a growth stock or a value stockPre Market Forecasts For Smart Trading - jammulinksnews.com
Enveric Biosciences Inc. Could See a Relief Rally From SupportLow Risk Swing Trade Opportunities Identified - metal.it
What are the latest earnings results for Enveric Biosciences Inc.Expert Picks Forecasts That Work - jammulinksnews.com
How many analysts rate Enveric Biosciences Inc. as a “Buy”Entry Signal Growth Plan For Every Investor - jammulinksnews.com
Enveric Biosciences Inc.’s Beta Climbs After Market VolatilityEntry Alert With Low Drawdown Strategy Noted - metal.it
Heatmap Data Shows High Activity in Enveric Biosciences Inc. SectorExpert Verified Stock Trade Ideas Backed by Data - metal.it
Is a relief rally coming for Enveric Biosciences Inc. holdersMarket Momentum Signal Generator Shows Trends - metal.it
Is it time to cut losses on Enveric Biosciences Inc.Top Performing Stock Insights Released Daily - metal.it
Published on: 2025-07-29 05:33:14 - metal.it
How strong is Enveric Biosciences Inc. company’s balance sheetBest Dividend Report For Fast Growth - jammulinksnews.com
What is the dividend policy of Enveric Biosciences Inc. stockAI Powered Growth Plan From AI Tools - jammulinksnews.com
Why is Enveric Biosciences Inc. stock attracting strong analyst attentionLow Risk Picks With Proven Results - jammulinksnews.com
What makes Enveric Biosciences Inc. stock price move sharplyUnlock daily market insights for better trades - jammulinksnews.com
Advanced analytics toolkit walkthrough for Enveric Biosciences Inc.Watchlist Generator for Smart Money Signals - Newser
Why Enveric Biosciences Inc. stock attracts strong analyst attentionFast Return Equity Trade Forecast Points to Small Caps - metal.it
Key resistance and support levels for Enveric Biosciences Inc. Free Quick Gain Stock Watch With Indicators - Newser
Does Enveric Biosciences Inc. stock perform well during market downturnsExceptional ROI - jammulinksnews.com
Is Enveric Biosciences Inc. a Top Dividend Stock to Watch in 2025Technical Breakout List - metal.it
How volatile is Enveric Biosciences Inc. stock compared to the marketGrow your portfolio with growth-oriented stocks - jammulinksnews.com
Is Enveric Biosciences Inc. stock overvalued or undervaluedMaximize returns with disciplined trading - jammulinksnews.com
Published on: 2025-07-27 21:57:18 - jammulinksnews.com
How Enveric Biosciences Inc. stock performs during market volatilityInvestor Favorite Picks - Newser
Published on: 2025-07-27 16:52:31 - jammulinksnews.com
What analysts say about Enveric Biosciences Inc. stockFree Stock Chart Pattern Guide - PrintWeekIndia
Enveric Biosciences Inc. Stock Analysis and ForecastExplosive trading opportunities - PrintWeekIndia
How high can Enveric Biosciences Inc. stock price go in 2025Consistent wealth multiplication - jammulinksnews.com
Enveric Biosciences Secures Second USPTO Notice of Allowance for EVM401 Series - AInvest
Enveric’s Latest Patent Signals a Clear Path Forward for PTSD Drug Development - microdose.buzz
Enveric Biosciences receives second patent allowance for PTSD drug By Investing.com - Investing.com Canada
Enveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series - Business Wire
What drives Enveric Biosciences Inc. stock priceExceptional growth trajectory - Autocar Professional
Enveric Biosciences Inc Stock (ENVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):